Macquarie Group
AGL icon

Macquarie Group’s Agilon Health AGL Stock Holding History

Macquarie Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19
Closed -$3K – 1897
2024
Q1 		$3K Buy
+19
New +$3.16K ﹤0.01% 1616
2023
Q4 		– Sell
-132
Closed -$58K – 1639
2023
Q3 		$58K Sell
132
-5
-4% -$2.26K ﹤0.01% 1581
2023
Q2 		$59K Sell
137
-1,819
-93% -$1.02M ﹤0.01% 1609
2023
Q1 		$1.16M Buy
+1,956
New +$1.1M ﹤0.01% 1328
2022
Q4 		– Sell
-157
Closed -$144K – 1749
2022
Q3 		$144K Sell
157
-89
-36% -$53.3K ﹤0.01% 1673
2022
Q2 		$134K Buy
+246
New +$124K ﹤0.01% 1796

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's AGL Position: Q2 2024 in Review

Macquarie Group sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 19 shares — an estimated $3K sold.

Macquarie Group first reported a position in AGL in Q2 2022 and held it in 6 quarters. The position peaked at $1.16M in Q1 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Macquarie Group reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 19 Agilon Health shares in Q2 2024, an estimated $3K.
  • Macquarie Group first reported a position in Agilon Health in Q2 2022 and held it in 6 quarters.
  • Macquarie Group's Agilon Health position peaked at $1.16M in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.